Abstract
(Anesth Analg. 2018;126:1809–1811) Although phenylephrine is the first-choice vasopressor for the prevention and treatment of maternal hypotension during spinal anesthesia for cesarean delivery, its sole action as an alpha-adrenergic agonist can cause significant dose-dependent bradycardia, which in turn, may compromise fetal health. Consequently, norepinephrine, which has both alpha-1-adrenergic and beta-1-adrenergic activity has been proposed as an alternative.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
